COMMUNIQUÉS West-GlobeNewswire

-
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
11/06/2025 -
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program
11/06/2025 -
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
11/06/2025 -
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
11/06/2025 -
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
11/06/2025 -
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
11/06/2025 -
Project 55 Launches Free Mental Health First Responder Training for Public Use
11/06/2025 -
Moleculin Participates in Virtual Investor “What This Means” Segment
11/06/2025 -
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
11/06/2025 -
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
11/06/2025 -
Cabaletta Bio Announces Pricing of Public Offering of Securities
11/06/2025 -
Gapin Institute and Bauman Medical Announce Strategic Partnership – “Peak Launch: Personalized Longevity and Hair Optimization—powered by Gapin Institute for Bauman Medical”
11/06/2025 -
CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics
11/06/2025 -
ACHC and BOC Partner to Support DMEPOS Suppliers Amid Market Changes
11/06/2025 -
Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families
11/06/2025 -
LQpay Expands Compliant Surcharging Solution, Optimizing Payment Strategy for Healthcare Practices
11/06/2025 -
Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities
11/06/2025 -
Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology
11/06/2025 -
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
11/06/2025
Pages